The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Reason and analysis for variations in the clinical pathway of breast cancer
Author(s): 
Pages: 41-43
Year: Issue:  7
Journal: Hospital Management Forum

Keyword:  临床路径变异分析乳腺癌;
Abstract: 目的 通过分析临床路径在乳腺癌诊疗过程中的变异情况,提高医疗质量管理.方法 选择我院66例进入临床路径的乳腺癌患者,详细记录变异情况,应用不同的评价方法对变异进行分析.结果 66例乳腺癌患者中,正性变异发生率为13.64%,负性变异发生率为86.36%;医院系统相关的变异为13.92%,病人相关的变异占71.79%,与医务人员相关的变异发生率为14.29%;可控变异发生率为29.30%,不可控变异发生率为70.70%.结论 对乳腺癌患者诊治过程中临床路径变异情况分析,有利于医疗质量的持续改进,并制定出更加科学合理的临床路径.
Related Articles
No related articles found